C12Y 205/01059
Protein geranylgeranyltransferase type i
Official title: Protein geranylgeranyltransferase type I (2.5.1.59)
C12Y205/01059 (Protein geranylgeranyltransferase type i) appears on 4 US grants and 11 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 11
- Assignees
- 5
- Inventors
- 13
- Latest grant
- 28 Mar 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 2 | 2 |
| 2023 | 1 | 1 |
| 2024 | 0 | 3 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Compositions and methods for making (R)-reticuline and precursors thereof28 Mar 2023US 11,613,770 B2Antheia, Inc.
- Codon optimized REP1 genes and uses thereof13 Dec 2022US 11,524,081 B24D Molecular Therapeutics Inc.
- Codon optimized REP1 genes and uses thereof14 Jun 2022US 11,357,870 B24D Molecular Therapeutics Inc.
- Compositions and methods for making (R)-Reticuline and precursors thereof29 Jan 2019US 10,190,141 B2Epimeron Inc.
- Temperature-responsive nano-biomaterials from genetically encoded farnesylated proteins27 Feb 2025US 2025/0066831 A1Syracuse University
- Codon optimized rep1 genes and uses thereof31 Oct 2024US 2024/0358859 A14D Molecular Therapeutics Inc.
- Modulation of hypoxia associated with stroke25 Jan 2024US 2024/0026399 A1Omniox.Inc.
- Compositions and methods for making (r)-reticuline and precursors thereof4 Jan 2024US 2024/0002894 A1Antheia, Inc.
- Codon optimized rep1 genes and uses thereof25 May 2023US 2023/0158172 A14D Molecular Therapeutics Inc.
Most cited
By later US patents